Search

Your search keyword '"Fätkenheuer, Gerd"' showing total 1,097 results

Search Constraints

Start Over You searched for: Author "Fätkenheuer, Gerd" Remove constraint Author: "Fätkenheuer, Gerd"
1,097 results on '"Fätkenheuer, Gerd"'

Search Results

51. Treatment of Early Syphilis

55. Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial

56. Training in infectious diseases across Europe in 2021 – a survey on training delivery, content and assessment

58. Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1

59. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

60. Combination therapy with anti-HIV-1 antibodies maintains viral suppression

61. Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome

62. Immune response to mRNA ‐based COVID ‐19 booster vaccination in people living with HIV

63. Adressen

64. HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

67. Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

70. Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

71. The “Choosing Wisely” initiative in infectious diseases

74. Publisher Correction: Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection

75. Infektiologie

76. Infektiologie

78. Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

79. Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection

80. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

81. Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients

82. Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery

87. Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection

88. Implementing the Lolli-Method and pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: a pilot project

89. Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

91. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

94. Surgical Procedure Time and Mortality in Patients with Infective Endocarditis Caused by Staphylococcus aureus or Streptococcus Species

95. CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue

96. Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial

98. SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma

Catalog

Books, media, physical & digital resources